Tronson Natalie C, Schrick Christina, Fischer Andre, Sananbenesi Farahnaz, Pagès Gilles, Pouysségur Jacques, Radulovic Jelena
Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Neuropsychopharmacology. 2008 Jun;33(7):1570-83. doi: 10.1038/sj.npp.1301550. Epub 2007 Aug 22.
Human anxiety is frequently accompanied by depression, and when they co-occur both conditions exhibit greater severity and resistance to treatment. Little is known, however, about the molecular processes linking these emotional and mood disorders. Based on previously reported phosphorylation patterns of extracellular signal-regulated kinase (ERK) in the brain, we hypothesized that ERK's upstream activators intertwine fear and mood regulation through their hippocampal actions. We tested this hypothesis by studying the upstream regulation of ERK signaling in behavioral models of fear and depression. Wild-type and ERK1-deficient mice were used to study the dorsohippocampal actions of the putative ERK activators: mitogen-activated and extracellular signal-regulated kinase (MEK), protein kinase C (PKC), and cAMP-dependent protein kinase (PKA). Mice lacking ERK1 exhibited enhanced fear extinction and reduced depression caused by overactivation of ERK2. Both behaviors were reversed by inhibition of MEK, however the extinction phenotype depended on hippocampal, whereas the depression phenotype predominantly involved extrahippocampal MEK. Unexpectedly, inhibition of PKC accelerated extinction and decreased depression by ERK-independent mechanisms, whereas inhibition of PKA did not produce detectable molecular or behavioral effects in the employed paradigm. These results indicate that, contrary to fear conditioning but similar to mood stabilization, extinction of fear required upregulation of MEK/ERK and downregulation of ERK-independent PKC signaling. The dissociation of these pathways may thus represent a common mechanism for fear and mood regulation, and a potential therapeutic option for comorbid anxiety and depression.
人类焦虑常常伴有抑郁,当二者同时出现时,这两种情况都会表现出更高的严重程度和对治疗的抵抗性。然而,对于连接这些情绪和心境障碍的分子过程,我们却知之甚少。基于先前报道的大脑中细胞外信号调节激酶(ERK)的磷酸化模式,我们推测ERK的上游激活剂通过其在海马体中的作用将恐惧和情绪调节交织在一起。我们通过研究恐惧和抑郁行为模型中ERK信号的上游调节来验证这一假设。利用野生型和ERK1缺陷型小鼠来研究假定的ERK激活剂的背侧海马体作用:丝裂原活化蛋白激酶(MEK)、蛋白激酶C(PKC)和环磷酸腺苷依赖性蛋白激酶(PKA)。缺乏ERK1的小鼠表现出恐惧消退增强,以及由ERK2过度激活引起的抑郁减轻。两种行为都通过抑制MEK得到逆转,然而消退表型取决于海马体,而抑郁表型主要涉及海马体外的MEK。出乎意料的是,抑制PKC通过ERK非依赖性机制加速了消退并减轻了抑郁,而抑制PKA在所采用的范式中未产生可检测到的分子或行为效应。这些结果表明,与恐惧条件反射相反但与情绪稳定相似,恐惧的消退需要MEK/ERK上调和ERK非依赖性PKC信号下调。因此,这些途径的分离可能代表了恐惧和情绪调节的共同机制,以及共病焦虑和抑郁的潜在治疗选择。